Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Public ClinicalTrials.gov record NCT03415282. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis
Study identification
- NCT ID
- NCT03415282
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Dermavant Sciences GmbH
- Industry
- Enrollment
- 24 participants
Conditions and interventions
Conditions
Interventions
- RVT-501 0.5% topical ointment Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 4, 2018
- Primary completion
- Jul 23, 2018
- Completion
- Aug 6, 2018
- Last update posted
- May 10, 2018
2018
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermavant Investigational Site | Anniston | Alabama | 36207 | — |
| Dermavant Investigational Site | Irvine | California | 92617 | — |
| Dermavant Investigational Site | Jacksonville | Florida | 32256 | — |
| Dermavant Investigational Site | Miami | Florida | 33172 | — |
| Dermavant Investigational Site | Miami | Florida | 33174 | — |
| Dermavant Investigational Site | Stockbridge | Georgia | 30281 | — |
| Dermavant Investigational Site | Indianapolis | Indiana | 46256 | — |
| Dermavant Investigational Site | Raleigh | North Carolina | 27612 | — |
| Dermavant Investigational Site | Arlington | Texas | 76011 | — |
| Dermavant Investigational Site | San Antonio | Texas | 78213 | — |
| Dermavant Investigational Site | San Antonio | Texas | 78229 | — |
| Dermavant Investigational Site | Richmond | Virginia | 23220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03415282, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 10, 2018 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03415282 live on ClinicalTrials.gov.